AlphaGrep UK’s Oracle ORCL Stock Holding History

AlphaGrep UK’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,590	Closed	-$380K	–	902
2026 Q2	$380K	Buy	2,590 +794	+44%	+$144K	0.11%	347
2026 Q1	$264K	Buy	+1,796	New	+$292K	0.08%	570

Other funds holding ORCL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

AlphaGrep UK's ORCL Position: Q3 2026 in Review

AlphaGrep UK sold out of Oracle (ORCL) in Q3 2026, closing a stake of 2,590 shares — an estimated $380K sold.

AlphaGrep UK first reported a position in ORCL in Q1 2026 and held it in 2 quarters. The position peaked at $380K in Q2 2026. 3,030 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

AlphaGrep UK reported no remaining Oracle position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 2,590 Oracle shares in Q3 2026, an estimated $380K.
AlphaGrep UK first reported a position in Oracle in Q1 2026 and held it in 2 quarters.
AlphaGrep UK's Oracle position peaked at $380K in Q2 2026.
3,030 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.